Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!

Ítems similars

• Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
  per: Honore, Patrick M., et al.
  Publicat: (2015)
• Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
  per: Jacobs, Rita, et al.
  Publicat: (2015)
• Continuous renal replacement therapy in critically ill patients does not affect urinary neutrophil gelatinase-associated lipocalin levels
  per: Vasileiadis, Ioannis, et al.
  Publicat: (2015)
• Mortality prediction of serum neutrophil gelatinase-associated lipocalin in patients requiring continuous renal replacement therapy
  per: Park, Yohan, et al.
  Publicat: (2021)
• Plasma neutrophil gelatinase-associated lipocalin (NGAL) for timing of initiation of renal replacement therapy for acute kidney injury?
  per: Hoste, Eric A., et al.
  Publicat: (2018)